|
|
News Breaks | | | | October 15, 2012 | | 04:55 EDT |  | PFE, PFE, PFE, AMGN, AMGN, AMGN, BAYRY, BAYRY, BAYRY, AZN, AZN, AZN, SNY, SNY, SNY, ONXX, ONXX, ONXX, ISIS, ISIS, ISIS, ALXN, ALXN, ALXN, THLD, THLD, THLD, LLY, LLY, LLY | Worldwide Business Research to host a conference
BioNetwork West is being held in Laguna Niguel, California on October 15-17. | |
|
News For PFE;THLD;ALXN;ISIS;ONXX;SNY;AZN;BAYRY;AMGN;LLY From The Last 14 Days Check below for free stories on PFE;THLD;ALXN;ISIS;ONXX;SNY;AZN;BAYRY;AMGN;LLY the last two weeks. |
|
|
| May 17, 2013 | | 10:36 EDT | | AZN | Leerink's major/specialty pharma analyst holds analyst/Industry conference call
 Subscribe for More Information | | | 08:41 EDT |  | AZN | Impax commenced shipment of authorized generic Zomig
Impax (IPXL) announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig tablets, as part of an agreement with AstraZeneca (AZN). Zomig is indicated for the treatment of migraine headaches in adults. According to IMS Health data, U.S. sales of Zomig tablets and orally disintegrating tablets were approximately $196M in the 12 months ended April 2013. | | | 08:03 EDT | | SNY | Sanofi reports positive topline results from pivotal Phase III Jakarta study
Subscribe for More Information | | | 06:33 EDT | | BAYRY | American Thoracic Society to hold a conference
Subscribe for More Information | | | 05:18 EDT | | SNY | Sanofi says JAK2 inhibitor for myelofibrosis met primary endpoint
Subscribe for More Information | | | May 16, 2013 | | 08:55 EDT | | LLY, PFE | BofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call
Subscribe for More Information | | | May 15, 2013 | | 15:16 EDT | | SNY | Sanofi systemic sclerosis treatment designated for orphan drug status
Subscribe for More Information | | | 11:43 EDT | | BAYRY | Bayer announces FDA approval for Xofigo as CRPC treatment
Subscribe for More Information | | | 05:39 EDT | | SNY | Sanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information | | | May 14, 2013 | | 09:09 EDT | | LLY | Eli Lilly announces CEO John Lechleiter recovering from surgery
Subscribe for More Information | | | | 07:24 EDT | | AZN, LLY | EBD Group to host a conference
BioTrinity 2013 is being held in Newbury, England on May 14-16. | | | May 13, 2013 | | 16:53 EDT |  | AZN | Optimer gets bids from AstraZeneca, Cubist, Astellas, Bloomberg says
Optimer (OPTR) has received first round bids from AstraZeneca (AZN), Cubist (CBST), and Astellas, reports Bloomberg, citing people familiar with the matter. Shares of Optimer spiked higher following the report, closing up $1.85, or 14.44%, to $14.66. The report notes the company disclosed almost three months ago it was exploring its strategic options. Reference Link | | | 15:55 EDT | | AZN | Optimer gets first round bids from AstraZeneca, Cubist, Bloomberg says
Subscribe for More Information | | | 09:44 EDT | | SNY | Several companies reportedly interested in buying Adcock Ingram, Globes says
Subscribe for More Information | | | 08:55 EDT | | AMGN | Biosimiliar drug bill to be taken up in Senate, LA Times reports
Subscribe for More Information | | | 07:30 EDT | | SNY | TechConnect to host a summit
2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. | | | May 10, 2013 | | 16:29 EDT |  | PFE | On The Fly: Closing Wrap
Subscribe for More Information | | | 12:31 EDT | | PFE | On The Fly: Midday Wrap
Subscribe for More Information | | | 11:48 EDT | | SNY, PFE, LLY, AZN | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information | | | 09:21 EDT | | PFE | On The Fly: Pre-market Movers
Subscribe for More Information | | |
|
|
|
|
|
|
